Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc.’s Chief Financial Officer, Brett Sandercock, reported a transaction involving the acquisition of 2,710 shares of ResMed common stock, which were performance-based restricted stock units earned upon meeting specific performance metrics. This transaction reflects the company’s commitment to aligning executive compensation with performance outcomes, potentially impacting stakeholder perceptions positively by demonstrating a focus on achieving strategic goals.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders and respiratory care. Their primary products include devices for sleep apnea treatment and other respiratory conditions, catering to a global market with a strong emphasis on innovation and patient care.
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.